Secondary analysis of a waitlist-controlled trial in treatment-resistant depression: in 29 participants given psilocybin-assisted psychotherapy, anhedonia (SHAPS) scores fell significantly by the 2-week endpoint (p=0.001), with improvements at 3 and 6 months.
Secondary analysisn = 30
Kaczmarek et al. Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression